Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS

Overview of attention for article published in Nephrology Dialysis Transplantation, May 2026

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 10,469 followers.

RT @MayoClinicNeph: Under-enrollment in rare kidney disease trials: lessons learned from the PRIVENT recurrent FSGS. @h4amer @NDTsocial h…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.